Hims & Hers Health (HIMS) Current Leases (2021 - 2026)
Hims & Hers Health (HIMS) posted Current Leases of $5.6 million for Q1 2026, up 15.2% sequentially from $4.8 million in Q4 2025, and up 49.33% YoY from $3.7 million in Q1 2025.
Hims & Hers Health (HIMS) Current Leases (2021 - 2026) Analysis & Trends
Hims & Hers Health has reported Current Leases for 6 years, with the latest figure at $5.6 million in Q1 2026.
- Quarterly Current Leases rose 49.33% year-over-year to $5.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.6 million (up 49.33% YoY) and the FY2025 annual result came in at $4.8 million, up 156.38% from the prior year.
- Current Leases advanced to $5.6 million in Q1 2026 per HIMS's latest filing, from $4.8 million in the prior quarter.
- Over five years, Current Leases peaked at $5.6 million in Q1 2026 and troughed at $1.3 million in Q4 2023.
- A 5-year average of $2.4 million and a median of $1.8 million in 2024 frame the typical range for Current Leases.
- The sharpest annual moves came in 2023 and 2025: Current Leases declined 22.74% in 2023, then soared 156.38% in 2025.
- Over 5 years, Current Leases stood at $1.7 million in 2022, then slipped by 22.74% to $1.3 million in 2023, then jumped by 47.46% to $1.9 million in 2024, then soared by 156.38% to $4.8 million in 2025, then rose by 15.2% to $5.6 million in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $5.6 million, $4.8 million, and $3.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Hims & Hers Health | 7.42 Bn | 6.57 Bn | 480.80 Mn | 11.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.55 Mn |
| Mar 31, 2026 | 5.58 Mn |
| Dec 31, 2025 | 4.84 Mn |
| Sep 30, 2025 | 3.42 Mn |
| Jun 30, 2025 | 3.14 Mn |
| Mar 31, 2025 | 3.74 Mn |
| Dec 31, 2024 | 1.89 Mn |
| Sep 30, 2024 | 1.79 Mn |
| Jun 30, 2024 | 1.63 Mn |
| Mar 31, 2024 | 1.54 Mn |
| Dec 31, 2023 | 1.28 Mn |
| Sep 30, 2023 | 1.93 Mn |
| Jun 30, 2023 | 1.80 Mn |
| Mar 31, 2023 | 1.70 Mn |
| Dec 31, 2022 | 1.66 Mn |
| Sep 30, 2022 | 1.61 Mn |
| Jun 30, 2022 | 1.40 Mn |
| Mar 31, 2022 | 1.39 Mn |
| Dec 31, 2021 | 1.37 Mn |